Company Name:Loxo Oncology Inc.
CEO:

Sector: Healthcare
Industry:Biotechnology

Exchange: NASDAQ Global Market

Country: USA

Description: Loxo Oncology Inc is a biopharmaceutical company. It is engaged in the development of selective medicines for patients with genetically defined cancers.


Key numbers

Market Capitalization:
Shares Outstanding: 30755000
Float: 27487520
Next Earning Date:
TTm EPS:
TTm Dividend Rate:
200 days moving average:
50 days moving average:
One day percent Change: -0.03



2017-12-31, 2018-03-31, 2018-06-30, 2018-09-30,
2017-12-31, 2018-03-31, 2018-06-30, 2018-09-30,
2014-12-31, 2015-12-31, 2016-12-31, 2017-12-31,
2014-12-31, 2015-12-31, 2016-12-31, 2017-12-31,